ABS CGSO Practice Questions - ABS Complex General Surgical Oncology Certifying Examination Exam

Access More Questions

A 48-year-old BRCA1 germline mutation carrier with triple-negative 2.8 cm breast cancer completes neoadjuvant AC-T with residual 1.2 cm invasive disease and a positive SLN at lumpectomy. Per the OlympiA trial, what adjuvant systemic therapy is indicated in addition to radiation?

Adjuvant capecitabine alone One year of olaparib 300 mg twice daily Adjuvant pembrolizumab Tamoxifen for 5 years

Correct Answer:

One year of olaparib 300 mg twice daily

Access more questions from this quiz

Continue to ABS CGSO Practice Questions - ABS Complex General Surgical Oncology Certifying Examination Exam for more practice questions and the full quiz experience.

Access More Questions